European Investor
02 Dec 2025, 16:48
Thermo Fisher Scientific (NYSE: TMO) announced that its finance subsidiary, Thermo Fisher Scientific (Finance I) B.V., has completed a €2.1 billion notes offering. The issuance includes €1.0 billion in Floating Rate Senior Notes due 2027 and €1.1 billion in 3.628% Senior Notes due 2035, both fully guaranteed by Thermo Fisher on a senior unsecured basis.
The debt was issued under the company’s existing indenture structure and sold through an underwriting syndicate led by Barclays, BNP Paribas, HSBC Continental Europe and Morgan Stanley. Thermo Fisher expects net proceeds of approximately €2.09 billion, which will be used for general corporate purposes, including potential acquisitions, refinancing, working capital, capital expenditures or share repurchases.
The debt was issued under the company’s existing indenture structure and sold through an underwriting syndicate led by Barclays, BNP Paribas, HSBC Continental Europe and Morgan Stanley. Thermo Fisher expects net proceeds of approximately €2.09 billion, which will be used for general corporate purposes, including potential acquisitions, refinancing, working capital, capital expenditures or share repurchases.
